Literature DB >> 32285959

Long-term risk of hip or forearm fractures in older occasional users of benzodiazepines.

Hélène Carrier1,2,3,4, Sébastien Cortaredona1,2, Viviane Philipps5, Hélène Jacqmin-Gadda5, Marie Tournier5,6, Hélène Verdoux5,6, Pierre Verger1,2,4.   

Abstract

AIMS: This article sought to study the association between patterns of benzodiazepine (BZD) use and the risk of hip and forearm fractures in people aged 50 and 75 years or more.
METHODS: In a representative cohort of the French National Health Insurance Fund of individuals aged 50 years or older (n = 106 437), we followed up BZD dispensing (reflecting their patterns of use) and the most frequent fall-related fractures (hip and forearm) for 8 years. We used joint latent class models to simultaneously identify BZD dispensing trajectories and the risk of fractures in the entire cohort and in those 75 years or older). We used a survival model to estimate the adjusted hazard ratios (aHRs) between these trajectories and the risk of fractures.
RESULTS: In the entire cohort, we identified 5 BZD trajectories: non-users (76.7% of the cohort); occasional users (15.2%); decreasing users (2.6%); late increasing users (3.0%); and early increasing users (2.4%). Compared with non-users, fracture risk was not increased in either occasional users (aHR = 0.99, 95% confidence interval [CI] 0.99-1.00) or in decreasing users (aHR = 0.90, 95% CI 0.74-1.08). It was significantly higher in early increasing users (aHR = 1.86, 95% CI 1.62-2.14) and in late increasing users (aHR = 1.39, 95% CI 1.15-1.60). We observed similar trajectories and risk levels in the people older than 75 years.
CONCLUSION: Occasional BZD use, which is compatible with current recommendations, was not associated with an excess risk of the most frequent fall-related fractures in people older than 50 or 75 years.
© 2020 The British Pharmacological Society.

Entities:  

Keywords:  adverse drug reactions; benzodiazepines; drug utilization; pharmacoepidemiology

Mesh:

Substances:

Year:  2020        PMID: 32285959      PMCID: PMC7576621          DOI: 10.1111/bcp.14307

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  33 in total

1.  Impact of duration of antidepressant treatment on the risk of occurrence of a new sequence of antidepressant treatment.

Authors:  H Verdoux; A Cougnard; A Thiébaut; M Tournier
Journal:  Pharmacopsychiatry       Date:  2011-02-16       Impact factor: 5.788

2.  Psychotropics and weak opioid analgesics in plasma samples of older hip fracture patients - detection frequencies and consistency with drug records.

Authors:  Ragnhild Birkeland Waade; Espen Molden; Mette Irene Martinsen; Monica Hermann; Anette Hylen Ranhoff
Journal:  Br J Clin Pharmacol       Date:  2017-03-09       Impact factor: 4.335

3.  French national health insurance information system and the permanent beneficiaries sample.

Authors:  P Tuppin; L de Roquefeuil; A Weill; P Ricordeau; Y Merlière
Journal:  Rev Epidemiol Sante Publique       Date:  2010-07-03       Impact factor: 1.019

4.  Trajectory analysis of anxiolytic dispensing over 10 years among new users aged 50 and older.

Authors:  P Verger; B Mmadi Mrenda; S Cortaredona; M Tournier; H Verdoux
Journal:  Acta Psychiatr Scand       Date:  2018-02-13       Impact factor: 6.392

Review 5.  Medication-related falls in the elderly: causative factors and preventive strategies.

Authors:  Allen R Huang; Louise Mallet; Christian M Rochefort; Tewodros Eguale; David L Buckeridge; Robyn Tamblyn
Journal:  Drugs Aging       Date:  2012-05-01       Impact factor: 3.923

Review 6.  Psychotropic drugs and falls in the elderly people: updated literature review and meta-analysis.

Authors:  Frédéric Bloch; Marie Thibaud; Benoit Dugué; Cyril Brèque; Anne-Sophie Rigaud; Gilles Kemoun
Journal:  J Aging Health       Date:  2010-10-14

7.  Adverse drug reactions in special populations - the elderly.

Authors:  E A Davies; M S O'Mahony
Journal:  Br J Clin Pharmacol       Date:  2015-05-22       Impact factor: 4.335

8.  Long-term risk of hip or forearm fractures in older occasional users of benzodiazepines.

Authors:  Hélène Carrier; Sébastien Cortaredona; Viviane Philipps; Hélène Jacqmin-Gadda; Marie Tournier; Hélène Verdoux; Pierre Verger
Journal:  Br J Clin Pharmacol       Date:  2020-05-10       Impact factor: 4.335

9.  Nonbenzodiazepine sleep medication use and hip fractures in nursing home residents.

Authors:  Sarah D Berry; Yoojin Lee; Shubing Cai; David D Dore
Journal:  JAMA Intern Med       Date:  2013-05-13       Impact factor: 21.873

10.  Discontinuing benzodiazepines: best practices.

Authors:  G Guaiana; C Barbui
Journal:  Epidemiol Psychiatr Sci       Date:  2016-01-28       Impact factor: 6.892

View more
  2 in total

1.  Long-term risk of hip or forearm fractures in older occasional users of benzodiazepines.

Authors:  Hélène Carrier; Sébastien Cortaredona; Viviane Philipps; Hélène Jacqmin-Gadda; Marie Tournier; Hélène Verdoux; Pierre Verger
Journal:  Br J Clin Pharmacol       Date:  2020-05-10       Impact factor: 4.335

2.  Long-term benzodiazepines and z-drug prescribing in Australian general practice between 2011 and 2018: A national study.

Authors:  Amelia Woods; Mumtaz Begum; David Gonzalez-Chica; Carla Bernardo; Elizabeth Hoon; Nigel Stocks
Journal:  Pharmacol Res Perspect       Date:  2022-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.